Fosinopril pharmacokinetics and pharmaco
β
T. W. B. Gehr; D. A. Sica; D. M. Grasela; I. Fakhry; J. Davis; K. L. Duchin
π
Article
π
1991
π
Springer
π
English
β 595 KB
The pharmacokinetics and pharmacodynamics of fosinoprilat, the diacid of fosinopril sodium, a new angiotensin-converting enzyme (ACE) inhibitor, were investigated after the oral administration of 10 mg of fosinopril sodium to 6 chronic ambulatory peritoneal dialysis (CAPD) patients. The results from